Literature DB >> 10348491

Protease inhibitors enhance levodopa effects in Parkinson's disease.

D Caparros-Lefebvre, A Lannuzel, F Tiberghien, M Strobel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10348491     DOI： 10.1002/1531-8257(199905)14:3<535::aid-mds1034>3.0.co;2-s

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  3 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit.

Authors:  Miguel F Gago; Maria José Rosas; Paulo Linhares; João Massano; António Sarmento; Rui Vaz
Journal:  Case Rep Neurol       Date:  2011-09-20

3.  Does antiretroviral therapy alter the course of Parkinson's disease in people living with HIV?

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Anand Moodley
Journal:  J Neurovirol       Date:  2021-08-05       Impact factor: 2.643
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.